Operating Lease, Right-of-Use Asset of Neurogene Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neurogene Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Neurogene Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,394,000, a 25% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Neurogene Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,394,000 -$799,000 -25% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $2,601,000 -$780,000 -23% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $2,803,000 -$762,000 -21% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $3,000,000 -$681,000 -18% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $3,193,000 -$5,492,000 -63% 30 Sep 2024 10-Q 18 Nov 2024 2024 Q3
Q2 2024 $3,381,000 -$5,754,000 -63% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $3,565,000 -$5,865,000 -62% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $3,681,000 -$663,000 -15% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $8,685,000 -$1,305,000 -13% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $9,135,000 -$1,122,000 -11% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $9,430,000 -$1,086,000 -10% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $4,344,000 -$6,422,000 -60% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $9,990,000 -$1,018,000 -9.2% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $10,257,000 -$987,000 -8.8% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $10,516,000 -$957,000 -8.3% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $10,766,000 +$612,000 +6% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 $11,008,000 +$610,000 +5.9% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $11,244,000 +$1,598,000 +17% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $11,473,000 +$1,173,000 +11% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $10,154,000 +$9,384,000 +1219% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $10,398,000 +$10,228,000 +6016% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $9,646,000 +$9,460,000 +5086% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $10,300,000 +$10,089,000 +4782% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $770,000 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $170,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $186,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $211,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.